menu
    • menu

    Company profile for Sight Sciences

    NEW Drugs in Dev: 2
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sight Sciences is a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry, glaucoma and dry eye disease. Founded in 2011, the company has developed, and is now commercial with intelligently designed and engineered products that target the underlying causes of the world’s most prevalent eye diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sight SciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4040 Campbell Ave, Suite 100 Menlo Park CA 94025
    Telephone
    Telephone
    877-266-1144
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sightsciences.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/in/mark-papini-a8106ba5/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sight Sciences To Release 2025 Financial Results On March 4, 2026
    Sight Sciences To Release 2025 Financial Results On March 4, 2026

    18 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/18/3240612/0/en/Sight-Sciences-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-March-4-2026.html

    GLOBENEWSWIRE
    18 Feb 2026
    Share Share
    Sight Sciences Reveals 2025 Financial Highlights
    Sight Sciences Reveals 2025 Financial Highlights

    13 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/13/3217649/0/en/Sight-Sciences-Announces-Preliminary-Unaudited-Fourth-Quarter-and-Full-Year-2025-Financial-Highlights.html

    GLOBENEWSWIRE
    13 Jan 2026
    Share Share
    OMNI Surgical System With Trusync Reduces IOP And Medication
    OMNI Surgical System With Trusync Reduces IOP And Medication

    11 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/11/3185297/0/en/New-Peer-Reviewed-Publications-Highlight-Effectiveness-of-OMNI-Surgical-System-with-TruSync-Technology-in-Reducing-IOP-and-Medication-Usage-in-Cataract-Combination-Procedures-Stand.html

    GLOBENEWSWIRE
    11 Nov 2025
    Share Share
    Sight Sciences Names Ali Bauerlein Coo & Jim Rodberg as CFO
    Sight Sciences Names Ali Bauerlein Coo & Jim Rodberg as CFO

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3183070/0/en/Sight-Sciences-Appoints-Ali-Bauerlein-as-Chief-Operating-Officer-and-Jim-Rodberg-as-Chief-Financial-Officer.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    Sight Sciences Boosts 2025 Revenue Forecast After Q3 Financials
    Sight Sciences Boosts 2025 Revenue Forecast After Q3 Financials

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3183087/0/en/Sight-Sciences-Reports-Third-Quarter-2025-Financial-Results-and-Raises-Full-Year-2025-Revenue-Guidance.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    Sight Sciences To Present At Two Upcoming Investor Conferences
    Sight Sciences To Present At Two Upcoming Investor Conferences

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3180835/0/en/Sight-Sciences-to-Present-at-Two-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search